CK-: co-transformant containing pBX-Rv2031p and pTRG-Rv3133c-delt

CK-: co-transformant containing pBX-Rv2031p and pTRG-Rv3133c-deltaC as a negative control (24). SsoDNA, an unrelated archaeal DNA sequence, was also used a negative control. (C) SPR assays for the binding of dnaA CHIR-99021 datasheet promoter chip by MtrA. (D) The specific interaction between the regulatory region of the M. tuberculosis dnaA gene was assayed by SPR. Unlabeled promoter DNA was used as competition

for the binding of MtrA with DNA on chip. An overlay plot was produced to show the interactions. The interaction of the purified MtrA protein with the dnaA promoter was confirmed by the interaction with the DNA on the chip. As shown in Fig. 1C, the biotinylated promoter DNA was first associated with the streptavidin (SA) chip (GE CYT387 chemical structure Healthcare). When an increasing concentration of MtrA protein (100-500 nM) was passed over the chip surface, a corresponding increasing response value was observed. This again indicated that the MtrA protein could bind with the dnaA promoter DNA (Fig. 1C). In contrast, heated inactive protein showed no response when it was passed over the chip (Fig. 1C). When an unspecific DNA, the promoter of Rv0467, was coated on the chip, no significant association for MtrA was observed (Additional file 2). In a further confirmatory experiment, 200 μM unlabeled promoter DNA was also added along with the MtrA protein. This DNA

competed with that on the chip for the available MtrA; here, a significantly lower response was observed

compared to a control with no competition (Fig. 1D). Characterization of the DNA-box motif in the dnaA promoter that allows MtrA binding Several short DNA Copanlisib concentration fragments (S1-S5) were used to precisely determine the DNA-box motif for the MtrA in this promoter region (Fig. 2A). As shown in Fig. 2B, a specific protein/DNA complex was observed on S1, S2, and S5, indicating that L-NAME HCl MtrA could recognize these DNA substrates. In contrast, no binding activity was observed for substrates S3 and S4, both of which lacked the 5-CACGCCG-3 or 5-CACGAGG-3 sequence box (Fig. 2A). Further confirmation of the specific interaction was obtained by conducting the competing surface plasmon resonance (SPR) assay with the unlabeled DNA fragments. As shown in Additional file 3, a significantly lower response was observed when either the unlabeled S2 or S5 was added together with MtrA, which indicated that they could compete the binding of MtrA with the promoter DNA on the chip. Therefore, these two sequence motifs appeared to be essential for the MtrA binding with the dnaA regulatory region. Figure 2 Characterization of the sequence motifs for MtrA in the M. tuberculosis dnaA gene promoter region. The DNA-binding assays of M. tuberculosis MtrA were performed using modified EMSA and SPR assays, as described in “”Materials and Methods”". (A) Several short DNA fragments were synthesized and used as DNA substrates, which covered a different dnaA gene promoter region.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>